Operating Lease, Right-of-Use Asset of IMMUNIC, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IMMUNIC, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • IMMUNIC, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $791,000, a 9.9% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

IMMUNIC, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $791,000 -$87,000 -9.9% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $975,000 +$47,000 +5.1% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $968,000 -$130,000 -12% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $991,000 -$308,000 -24% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $878,000 -$534,000 -38% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $928,000 -$927,000 -50% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,098,000 -$861,000 -44% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $1,299,000 -$253,000 -16% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,412,000 +$149,000 +12% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $1,855,000 +$1,110,000 +149% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $1,959,000 +$1,085,000 +124% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,552,000 +$604,000 +64% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $1,263,000 +$209,000 +20% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $745,000 -$420,000 -36% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $874,000 -$368,000 -30% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $948,000 +$47,000 +5.2% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $1,054,000 +$114,000 +12% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $1,165,000 +$169,000 +17% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $1,242,000 +$638,000 +106% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $901,000 +$268,000 +42% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $940,000 +$869,000 +1224% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $996,000 +$928,000 +1365% 30 Jun 2020 10-Q/A 03 Aug 2020 2020 Q2
Q1 2020 $604,000 +$592,000 +4933% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $633,000 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $71,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $68,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $12,000 31 Mar 2019 10-Q 10 Apr 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.